Vivani Medical (NASDAQ:VANI) Earns “Buy” Rating from HC Wainwright
Vivani Medical (NASDAQ:VANI – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $4.00 target price on the stock. HC Wainwright’s target price would suggest a potential upside of 247.83% from the company’s […]
Vivani Medical (NASDAQ:VANI – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $4.00 target price on the stock. HC Wainwright’s target price would suggest a potential upside of 247.83% from the company’s […]
